Moderna Inc.

Massachusetts
Pharmaceuticals Biotechnology and Life Sciences

Risk Level:

Rating - Caution
Medium Risk

Summary:

Moderna Inc. has policy requiring suppliers to have LGBTQ non-discrimination policies, does not have policy protecting employees from viewpoint discrimination, and requires implicit bias training for employees. However, Moderna has not used corporate funds to advance ideological groups hostile to freedom of expression. It has not publicly canceled business relationships due to views or beliefs. For these reasons, Moderna Inc. receives a Medium Risk rating.

Criteria
Risk Level
Rationale
Corporate Weaponization
Criteria

Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level
Rationale

Moderna has integrated ESG into its business practices, including a written policy requiring suppliers not to discriminate on the basis of LGBTQ identity (1)(2). There are no publicly known examples of Moderna firing employees or canceling contracts based on ideological differences.

Criteria

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level
Rationale

Moderna will donate to religiously-affiliated charitable organizations that provide their services in a non-sectarian manner (1).

Criteria

Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.

Risk Level
Rationale

Moderna Inc. does not have written policy protecting its employees from viewpoint discrimination (1).

Corporate Governance and Public Policy
Criteria

Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.

Risk Level
Rationale

Moderna Inc.’s CEO Stéphane Bancel signed the CEO Action for Diversity and Inclusion pledge (1). The company has integrated ESG into its business practices, including an emphasis on “implicit bias” training (2)(3).

Criteria

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level
Rationale

There are no publicly known cases of Moderna Inc. donating to idealogical groups hostile to freedom of expression (1).

Criteria

Uses corporate political contributions for ideological, non-business purposes.

Risk Level
Rationale

Moderna Inc. does not operate a PAC, but does lobby for issues that pertain to its business practices (1)(2). However, Moderna Inc. donates indirectly through 501(c)(4)’s like Biotechnology Innovation Organization, which contributes to policies, candidates, and PACs that benefit pharmaceutical organizations (3).

All links were last accessed and all information was updated on:
May 12, 2023

Company reports are intended for educational use only. Full Disclaimer

Generate Reports
Clear
Toast